PMC:7358770 / 34024-34210
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T506 | 4-15 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T507 | 19-32 | Chemical | denotes | nanoparticles | http://purl.obolibrary.org/obo/CHEBI_50803 |
| T508 | 114-121 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32679328-31647394-48281347 | 181-184 | 31647394 | denotes | 126 |
| T91461 | 181-184 | 31647394 | denotes | 126 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T211 | 0-186 | Sentence | denotes | The application of nanoparticles in vaccine formulations can not only improve the immunogenicity and stability of antigen, but also achieve targeted delivery and sustained release [126]. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T965 | 19-32 | GO:0031982 | denotes | nanoparticles |
| T966 | 82-96 | BV_15 | denotes | immunogenicity |
| T967 | 114-121 | CHEBI:59132;CHEBI:59132 | denotes | antigen |
| T83905 | 16-22 | CHEBI:16261;CHEBI:16261 | denotes | of nan |
| T60667 | 59-62 | NCBITaxon:7460 | denotes | n n |
| T82055 | 110-116 | UBERON:0000912 | denotes | of an |